Preclinical

Gates Foundation, Exscientia enter $70m agreement to develop COVID-19 treatments

14-Sep-2021 By Jenni Spinner

The pharma tech firm has forged a four-year partnership with the foundation to develop antivirals for COVID-19 and other viruses with pandemic potential.

NIH offers $185m to further understanding of the human genome

13-Sep-2021 By Jenni Spinner

The US medical research agency plans to offer funding over five years through a newly launched consortium, expected to include 30 sites across the country.

Recent FDA COVID-19 actions and updates

10-Sep-2021 By Jenni Spinner

The US agency continues to oversee vaccine and drug development, and to share information and advice for life-sciences professionals and civilians alike.

Neuroglee, Mayo Clinic partner on remote care management for Alzheimer’s

09-Sep-2021 By Jenni Spinner

The digital therapeutics firm's Neuroglee Connect remote care platform and virtual clinic is for patients with mild cognitive impairment, including Alzheimer’s.

Biomarker panel to elevate prostate cancer diagnostics: Berg

07-Sep-2021 By Jenni Spinner

The clinical-stage biotech firm and a number of high-profile partners have collaborated on biomarker technology to deliver a more accurate, less invasive option.

People on the Move: September 2021

02-Sep-2021 By Jenni Spinner

This month’s news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

Survey: cancer patients missing out on much-needed genetic testing

31-Aug-2021 By Jenni Spinner

According to patient-matching specialist TrialJectory, 90% of cancer patients know the vitality of genetic testing but more than half are not being tested.

Partnership fights to amplify Black women’s voice in breast cancer research

31-Aug-2021 By Jenni Spinner

The #BlackDataMatters movement aims to improve outcomes for Black women living with breast cancer by increasing their presence in vital clinical research.

Merck to collaborate with Ontada on data-driven cancer insights

26-Aug-2021 By Jenni Spinner

Merck (known as MSD outside the US and Canada) will partner with the data insights firm on solutions that progress real-world research and innovations.

Cloud lab solution empowers access of research tech from miles away

26-Aug-2021 By Jenni Spinner

Emerald Cloud Lab’s remote, automated laboratory technology puts pieces of advanced scientific equipment within the reach of smaller research outfits.

MMS support program to help ultra-rare disease research

24-Aug-2021 By Emily Jarecki

The CRO has launched an initiative that offers help navigating regulatory issues for ultra-rare disease patient advocacy groups that demonstrate a need.

Insilico Medicine uses AI to uncover preclinical candidate for kidney fibrosis

23-Aug-2021 By Jenni Spinner

The drug discovery company reportedly used AI-powered drug discovery to come up with a promising preclinical candidate for treatment of the kidney ailment.

Datavant, Real Chemistry form precision medicine partnership

23-Aug-2021 By Jenni Spinner

The two firms will work together on solutions to connect de-identified, first-party data to real-world data to help advance precision medicine development.

Paige, Perspectum forge AI-centered clinical trial alliance

19-Aug-2021 By Emily Jarecki

The digital pathology firm and image-analysis software developer will partner on artificial intelligence based solutions to improve trial decision making.

Trialbee partners with specialized CRO to accelerate precision medicine development

19-Aug-2021 By Jenni Spinner

The patient matching platform firm will work with Precision for Medicine on solutions to increase diversity, elevate enrollment and speed new therapies.

Trial complexity, info explosion driving data management evolution

17-Aug-2021 By Jenni Spinner

A leader from Veeva Systems shares perspective on what factors are impacting clinical trial data management, and how the industry can adapt to the changes.

Alzheimer’s research tool targets underrepresented groups

16-Aug-2021 By Emily Jarecki

The National Institute on Aging has launched Outreach Pro, an online tool aimed to help connect with underrepresented populations for Alzheimer’s trials.

Study examines long-term effects of COVID-19 on athletes' hearts

12-Aug-2021 By Jenni Spinner

The Heart of Athletes study, using Deloitte’s ConvergeHealth MyPath for Clinical platform, aims to examine heart inflammation in athletes with the virus.

Current FDA COVID-19 related actions and advice

11-Aug-2021 By Jenni Spinner

The US Food and Drug Administration has kept its staff busy with approvals, authorizations, and warnings related to various coronavirus-centered products.

BMS joins with Black colleges to increase pharma talent diversity

10-Aug-2021 By Jenni Spinner

The pharma firm is working with five US colleges and universities onto create programming designed to boost recruitment of Black talent in the industry

UIC studying IV drug as potential COVID-19 treatment

10-Aug-2021 By Emily Jarecki

The University of Illinois at Chicago has been given $6m from the US Department of Defense to develop a potential treatment for severe cases of COVID-19.

Virtual reality technology transforming COVID-19 drug discovery

09-Aug-2021 By Jenni Spinner

Nanome’s virtual reality tech is being put to use by Oak Ridge National Laboratory and top pharma firms to study COVID-19 and explore drug candidates.

Artificial intelligence stands to ‘revolutionize’ research: Bioclinica

05-Aug-2021 By Jenni Spinner

A leader from the clinical research tech specialist explains how the use of AI is increasing and outlines the many ways it could change the field.

Psychedelics research institute launches in Australia

03-Aug-2021 By Jenni Spinner

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

AstraZeneca, Regeneron join on obesity drug discovery

29-Jul-2021 By Jenni Spinner

The two companies are collaborating to research, develop and launch new small-molecule drug candidates aimed at treating obesity and related comorbidities.

New eLearning program aimed at enabling faster clinical adoption and improving patient access to ATMPs

26-Jul-2021 By Jane Byrne

A new UK eLearning program is targeted at healthcare and academic professionals to support their learning on advanced therapy medicinal products (ATMPs).

Next-level tech elevates clinical data management: AiCure

22-Jul-2021 By Jenni Spinner

A leader from the artificial intelligence solutions firm discusses how advanced analytical tools can help researchers make the most of mountains of data.

Most patients confident in personalized medicine: survey

20-Jul-2021 By Jenni Spinner

A recent survey conducted by dosing technology firm found that the vast majority (85%) of patients think that personalized medicine stands to improve care.

Novartis inks 10-year pledge to improve equity in research, care

20-Jul-2021 By Jenni Spinner

The pharma firm's partnership with 26 US Black colleges includes a $13.7m investment in trial and research centers at Morehouse School of Medicine.

Contract data analysis can help predict pharma demand: Agiloft

Contract data analysis can help predict pharma demand: Agiloft

19-Jul-2021 By Jenni Spinner

The process management solutions firm says drug companies could use contract data to get a better handle on predicting demand and adjusting product output.

COTA, MedStar Health partnership to use RWD in cancer research

15-Jul-2021 By Jenni Spinner

The oncology-centered analytics firm will work with the DC-area healthcare provider to delve into discovery and development of novel cancer treatments.

Ongoing training fills data management knowledge gaps: TriTiCon

14-Jul-2021 By Jenni Spinner

A leader from the clinical tech consultancy shares advice on how to employ training to help keep up with the rapidly evolving field of data management.

ACD/Labs, Science Data Experts establish AI partnership

14-Jul-2021 By Jenni Spinner

The two companies will work together to come up with solutions that use machine learning and artificial intelligence to help accelerate innovation in R&D.

From hesitancy to reliance: journey to real-world data acceptance

14-Jul-2021 By Jenni Spinner

According to a leader from CRO Quanticate, the research industry’s increased use of real-world data is leading to a broad range of benefits in trial work.

Pfizer, Biogen, and AbbVie collaborate on genetic database

13-Jul-2021 By Jenni Spinner

The genetic exome sequence analysis partnership has created a large database linking rare protein-coding genetic variants to human health and disease.

Rare disease specialists talk resources, research and hope

09-Jul-2021 By Jenni Spinner

During the Rare/Orphan Diseases, Special Patient Population webinar, a group of industry experts discussed challenges and opportunities faced in the field.

Experts to talk rare and orphan diseases, patient experience at webinar

01-Jul-2021 By Jenni Spinner

On July 7, a group of seasoned industry leaders will offer insights at Rare/orphan diseases, special patient population, a focused, free online event.

Scleroderma Foundation increases research funding by more than 100%

29-Jun-2021 By Jenni Spinner

The organization, focused on building awareness and finding therapies for the rare disease, is boosting its annual research funding to more than $2.7m USD.

Cancer patient survey shows COVID's impact on care decisions

25-Jun-2021 By Jenni Spinner

The survey, conducted by Ai-powered study matching company TrialJectory, indicates more patients than ever are interested in clinical trial participation post-pandemic.

Sanofi, CytoReason join forces on AI-based asthma research

24-Jun-2021 By Jenni Spinner

The project will use the artificial intelligence specialist’s cell-centered models and deconvolutions to gain insights for each individual asthma endotype.

COTA, University of Chicago to study racial disparities in cancer treatment

23-Jun-2021 By Jenni Spinner

The research collaboration is aimed at studying disparities in care with a focus on multiple myeloma, a cancer disproportionately affecting Black patients.

Cryo-EM advancements lead to ‘resolution revolution’: Thermo Fisher

22-Jun-2021 By Jenni Spinner

An academic researcher and and company expert discuss on how evolving cryogenic electron microscopy has led to high resolutions and accelerated results.

Jazz Pharma collaborates wiith groups on digital cancer community

17-Jun-2021 By Jenni Spinner

The pharma firm is collaborating with oncology organizations on Nothing Small About it, a resource for small-cell lung cancer patients and their loved ones.

DIA Annual Meeting 2021

DIA 2021 will explore the potential of RNA based therapeutics

17-Jun-2021 By Jane Byrne

In recent years, it has become clear that RNA molecules are an emerging as a class of therapeutics of relevance to multiple diseases, most recently including COVID-19 vaccines.

BioCelerate, FDA forge nonclinical data partnership

10-Jun-2021 By Jenni Spinner

The two organizations have formed a public-private partnership aimed at improving nonclinical research through better practices and standardization.

Michael J. Fox Foundation shares Parkinson’s genetic data

08-Jun-2021 By Jenni Spinner

In partnership with 23andMe, the group has released a wealth of new de-identified data from the largest-ever Parkinson’s cohort, to aid future research.

Skin-patch COVID-19 vaccine could offer enhanced antibody responses, according to preclinical data

03-Jun-2021 By Rachel Arthur

COVID-19 vaccination via Vaxxas’ novel high-density microarray patch showed 'significantly enhanced' T-cell and spike-specific antibody responses compared to needle delivery, according to a pre-print preclinical study published this week.

KU Cancer Center forges SIP partnership with Complion

03-Jun-2021 By Jenni Spinner

The University of Kansas Cancer Center has joined with trial tech provider Complion to develop a shared investigator platform for use in a range of studies.

People on the Move: June 2021

02-Jun-2021 By Jenni Spinner

This month’s roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.

BIO DIGITAL 2021

BIO Digital lands at a time of ‘unprecedented industry collaboration’

02-Jun-2021 By Jenni Spinner

The online pharma event will address the COVID-19 pandemic’s impact on the industry (and vice versa) and innovation in the face of formidable challenges.